Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A new long acting ophthalmic formulation of carteolol containing alginic acid.
Séchoy O, Tissié G, Sébastian C, Maurin F, Driot JY, Trinquand C. Séchoy O, et al. Among authors: trinquand c. Int J Pharm. 2000 Oct 10;207(1-2):109-16. doi: 10.1016/s0378-5173(00)00539-1. Int J Pharm. 2000. PMID: 11036236
Ocular hypotensive efficacy and safety of once daily carteolol alginate.
Demailly P, Allaire C, Trinquand C; Once-daily Carteolol Study Group. Demailly P, et al. Among authors: trinquand c. Br J Ophthalmol. 2001 Aug;85(8):921-4. doi: 10.1136/bjo.85.8.921. Br J Ophthalmol. 2001. PMID: 11466245 Free PMC article. Clinical Trial.
Alginic acid effect on carteolol ocular pharmacokinetics in the pigmented rabbit.
Tissié G, Sébastian C, Elena PP, Driot JY, Trinquand C. Tissié G, et al. Among authors: trinquand c. J Ocul Pharmacol Ther. 2002 Feb;18(1):65-73. doi: 10.1089/108076802317233225. J Ocul Pharmacol Ther. 2002. PMID: 11858616
[Ocular drug penetration].
Dupin O, Trinquand C. Dupin O, et al. Among authors: trinquand c. J Fr Ophtalmol. 2000 May;23(5):501-4; quiz 523. J Fr Ophtalmol. 2000. PMID: 10844313 French.
[Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C, Romanet JP, Nordmann JP, Allaire C; Groupe d'étude. Trinquand C, et al. J Fr Ophtalmol. 2003 Feb;26(2):131-6. J Fr Ophtalmol. 2003. PMID: 12660585 Clinical Trial. French.
Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.
Richard C, Trinquand C, Bloch-Michel E. Richard C, et al. Among authors: trinquand c. Eur J Ophthalmol. 1998 Oct-Dec;8(4):207-16. Eur J Ophthalmol. 1998. PMID: 9891891 Clinical Trial.
[Value of the conjunctival provocation test in evaluating the activity of 2 concentrations of anti-allergy eyedrops, mequitazine].
Dupin O, Compeyre S, Trinquand C, Persi L, Arnaud B. Dupin O, et al. Among authors: trinquand c. J Fr Ophtalmol. 1998 Jan;21(1):12-8. J Fr Ophtalmol. 1998. PMID: 9834894 Clinical Trial. French.
Fixed combination of carteolol and pilocarpine eye-drops: a double-blind randomized cross-over trial versus carteolol alone on intra-ocular pressure. The Study Group.
Hostyn P, Le Rebeller MJ, Trinquand C. Hostyn P, et al. Among authors: trinquand c. Eur J Ophthalmol. 1996 Jan-Mar;6(1):17-20. Eur J Ophthalmol. 1996. PMID: 8744845 Clinical Trial.
[Hypotensive action of 0.5% carteolol versus 0.1% timolol in patients with intraocular hypertension].
Allaire C, Trinquand C, Nordmann JP, Dascotte JC, George JL, Lesure P, Rouland JF, Khaitrine L, Sirbat D. Allaire C, et al. Among authors: trinquand c. J Fr Ophtalmol. 1995;18(1):22-6. J Fr Ophtalmol. 1995. PMID: 7738291 Clinical Trial. French.
Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group.
Bron AM, Garcher CP, Sirbat D, Allaire CM, Lablache-Combier MJ, Trinquand CJ. Bron AM, et al. Among authors: trinquand cj. Eur J Ophthalmol. 1997 Oct-Dec;7(4):351-6. Eur J Ophthalmol. 1997. PMID: 9457458 Clinical Trial.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page